<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Fulcrum Therapeutics, Inc.

    Fulcrum Therapeutics, Inc.

    We are a clinical-stage biopharmaceutical company focused on improving the lives o...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    National Research Corporation

    National Research Corporation

    NRC Health is one of the nation’s largest healthcare performance improvement fir...

    NRC Health is one of the nation’s largest hea...

    Filing Type:    PU
    DarioHealth Corp.

    DarioHealth Corp.

    DarioHealth Corp. (NASDAQ: DRIO) is a leading global Digital Therapeutics (DTx) co...

    DarioHealth Corp. (NASDAQ: DRIO) is a leading g...

    Filing Type:    PU
    ProPhase Labs, Inc.

    ProPhase Labs, Inc.

    ProPhase Labs is a diversified medical science and technology company. We develop,...

    ProPhase Labs is a diversified medical science ...

    Filing Type:    PU
    Recro Pharma, Inc.

    Recro Pharma, Inc.

    Recro Pharma (NASDAQ: REPH) is a revenue generating specialty pharmaceutical compa...

    Recro Pharma (NASDAQ: REPH) is a revenue genera...

    Filing Type:    PU
    UroGen Pharma Ltd.

    UroGen Pharma Ltd.

    UroGen Pharma Ltd. is a clinical-stage biopharmaceutical company developing advanc...

    UroGen Pharma Ltd. is a clinical-stage biopharm...

    Filing Type:    PU
    Allogene Therapeutics, Inc.

    Allogene Therapeutics, Inc.

    Allogene Therapeutics is a clinical stage biotechnology company pioneering the dev...

    Allogene Therapeutics is a clinical stage biote...

    Filing Type:    PU
    Odonate Therapeutics, Inc.

    Odonate Therapeutics, Inc.

    We are a pharmaceutical company dedicated to the development of best-in-class ther...

    We are a pharmaceutical company dedicated to th...

    Filing Type:    PU
    Gamida Cell Ltd.

    Gamida Cell Ltd.

    Gamida Cell is a clinical-stage biopharmaceutical company committed to developing ...

    Gamida Cell is a clinical-stage biopharmaceutic...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.